CVA
ZBH icon

Ceredex Value Advisors’s Zimmer Biomet ZBH Stock Holding History

Ceredex Value Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-308,325
Closed -$33.5M – 175
2024
Q2 		$33.5M Sell
308,325
-12,562
-4% -$1.48M 0.63% 68
2024
Q1 		$42.4M Sell
320,887
-31,565
-9% -$3.94M 0.74% 54
2023
Q4 		$43M Sell
352,452
-46,148
-12% -$5.15M 0.74% 52
2023
Q3 		$44.8M Buy
398,600
+158,375
+66% +$20.1M 0.79% 56
2023
Q2 		$35M Sell
240,225
-866,727
-78% -$118M 0.56% 71
2023
Q1 		$143M Sell
1,106,952
-161,041
-13% -$20.2M 2.23% 1
2022
Q4 		$162M Sell
1,267,993
-579,322
-31% -$67.2M 2.49% 1
2022
Q3 		$194M Sell
1,847,315
-54,845
-3% -$6.02M 3.16% 1
2022
Q2 		$200M Buy
1,902,160
+360,027
+23% +$42.7M 2.99% 3
2022
Q1 		$198M Buy
+1,542,133
New +$186M 2.38% 7
2021
Q4 		– Sell
-1,156,054
Closed -$165M – 136
2021
Q3 		$165M Sell
1,156,054
-379,175
-25% -$55.8M 1.86% 10
2021
Q2 		$240M Sell
1,535,229
-3,789
-0.2% -$614K 2.69% 6
2021
Q1 		$240M Buy
1,539,018
+39,346
+3% +$6.09M 2.78% 4
2020
Q4 		$225M Buy
1,499,672
+418,456
+39% +$59.1M 2.84% 4
2020
Q3 		$143M Buy
1,081,216
+164,698
+18% +$21.5M 2.1% 9
2020
Q2 		$106M Sell
916,518
-1,403,523
-60% -$162M 1.58% 14
2020
Q1 		$228M Sell
2,320,041
-89,105
-4% -$11.7M 3.91% 1
2019
Q4 		$351M Sell
2,409,146
-70,995
-3% -$9.8M 4.04% 1
2019
Q3 		$331M Sell
2,480,141
-136,426
-5% -$17.6M 3.92% 1
2019
Q2 		$300M Buy
2,616,567
+498,409
+24% +$58.4M 3.64% 2
2019
Q1 		$263M Sell
2,118,158
-24,451
-1% -$2.78M 3.23% 1
2018
Q4 		$216M Buy
2,142,609
+215,534
+11% +$24.2M 2.91% 1
2018
Q3 		$246M Sell
1,927,075
-22,400
-1% -$2.66M 2.77% 1
2018
Q2 		$211M Buy
1,949,475
+256,156
+15% +$27.9M 2.41% 1
2018
Q1 		$180M Buy
+1,693,319
New +$197M 2.13% 2

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Ceredex Value Advisors's ZBH Position: Q3 2024 in Review

Ceredex Value Advisors sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 308,325 shares — an estimated $33.5M sold.

Ceredex Value Advisors first reported a position in ZBH in Q1 2018 and held it in 25 quarters. The position peaked at $351M in Q4 2019. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Ceredex Value Advisors reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Ceredex Value Advisors sold 308,325 Zimmer Biomet shares in Q3 2024, an estimated $33.5M.
  • Ceredex Value Advisors first reported a position in Zimmer Biomet in Q1 2018 and held it in 25 quarters.
  • Ceredex Value Advisors's Zimmer Biomet position peaked at $351M in Q4 2019.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Ceredex Value Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.